ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Heart"

  • 2017 American Transplant Congress

    CD4 and CD8 T Cells: Respectively Reprogrammed and Recapitulated in the Neonate to Induce Transplant Tolerance.

    R. Bascom, K. Tao, L. West.

    Alberta Transplant Institute, University of Alberta, Edmonton, Canada

    Purpose: Non-conditioned neonatal mice develop acute graft-versus-host disease (aGVHD) when injected with adult allogeneic spleen and bone marrow cells (allo-SC/BMC). To prevent aGVHD and induce…
  • 2017 American Transplant Congress

    Validation of a Prediction Model for Cardiac Allograft Vasculopathy.

    E. Kransdorf, T. Aintablian, M. Kittleson, J. Patel, J. Kobashigawa.

    Cedars-Sinai Heart Institute, Los Angeles

    Introduction: Cardiac allograft vasculopathy (CAV) continues to limit the long-term success of heart transplantation. Although the progression of CAV can be slowed by tailored immunosuppression,…
  • 2017 American Transplant Congress

    Myocardial Improvement Six Months After Kidney Transplantation: Non-Contrast Cardiac Resonance Study.

    M. Contti, L. Morales-Buenrostro, H. Nga, P. Garcia, M. Barbosa, H. Takase, M. da Silva, A. Moyses.

    Internal Medicine, Botucatu School of Medicine, Botucatu, Sao Paulo, Brazil

    INTRODUCTION: Patients with stage 5 chronic kidney disease (CKD) are at increased risk of cardiovascular disease, considering left ventricular hypertrophy (LVH) an independent risk for…
  • 2017 American Transplant Congress

    Macrophage Specific Deletion of RhoA Inhibits Fractalkine Signaling and Abrogates Chronic Rejection of Cardiac Allograft.

    M. Kloc, Y. Liu, W. Chen, X. Li, R. Ghobrial.

    Surgery, Houston Methodist Hospital and Research Institute, Houston

    Objective. Chronic rejection of transplanted organs remains unresolved issue in organ transplantation. The chronic rejection is the most common cause of graft loss within 10…
  • 2017 American Transplant Congress

    Everolimus Reduces Carotid Intima-Media Thickness in Renal Transplant Recipients After One Year: Randomized Controlled Trial.

    P. Garcia, H. Takase, H. Nga, M. Contti, J. Hueb, L. Morales-Buenrostro.

    Internal Medicine, Botucatu Medical School - Universidade Estadual Paulista, Botucatu, São Paulo, Brazil

    Cardiovascular disease remains the commonest cause of death in kidney transplant recipients. Although some studies suggest that Mammalian target of rapamycin (mTOR) inhibitors may reduce…
  • 2016 American Transplant Congress

    αLFA-1 Monotherapy Induced Tolerance Is Dependent on Indirect CD8 T-Cells and Augments a Population of CD8 Cells with a Suppressor Phenotype.

    R. Plenter,1 M. Coulombe,2 T. Grazia,1 R. Gill,2 M. Zamora,1 B. Pietra.3

    1Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO; 2Department of Surgery, University of Colorado, Aurora, CO; 3Division of Pediatric Cardiology, University of Florida, Gainesville, FL.

    We sought to investigate some of the requirements for tolerance induction to cardiac allografts utilizing αLFA-1 mAb monotherapy. Having previously demonstrated that CD8 T-cells are…
  • 2016 American Transplant Congress

    Regression of Asymptomatic Cardiomyopathy and Clinical Outcome of Renal Transplant Recipients: Long-Term Extension of Two Randomized Controlled Trials.

    E. Paoletti, D. Bellino, L. Marsano, R. Russo, F. Masarino, G. Garibotto.

    Nephrology, Dialysis, and Transplantation, University of Genoa, Genoa, Italy.

    Background Asymptomatic left ventricular hypertrophy (LVH) is highly prevalent and associated with adverse outcome in renal transplant recipients (RTRs). Nonetheless, there are currently no available…
  • 2016 American Transplant Congress

    Absence of Receptors for C3a or C5a Prevent Alloreactive CD8 T Effector Cell (Teff) Expansion but Differentially Impact Memory (Tmem) Persistence Posttransplantation.

    D. Mathern, P. Heeger.

    Translational Transplant Research Center, Dept of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.

    As Tmem are known barriers to transplant survival and tolerance in animals and human transplant recipients, understanding factors that drive the formation and survival of…
  • 2016 American Transplant Congress

    Donor Sharpin Expression Modulates TNFα Mediated Inflammation and Cardiac Allograft Rejection in Mice.

    R. Ang,1 P. Heeger,2 A. Ting.1

    1Immunology Institute, Icahn School of Medicine at Mount Sinai, New York City, NY; 2Center for Translational Transplant Research, Icahn School of Medicine at Mount Sinai, New York City, NY.

    Increased systemic TNFα levels correlate with transplant rejection and severity of GVHD, and TNFα blockade can prolong graft survival and reduce severity of GVHD. These…
  • 2016 American Transplant Congress

    A Risk Quantification Score for Heart Transplants: A Heart Donor Risk Index.

    A. Israni,1,2 D. Zaun,1 J. Snyder,1 N. Salkowski,1 H. Xiong,1 B. Kasiske,1,2 M. Colvin,1,3 M. Colvin.1,3

    1Scientific Registry of Transplant Recipients, Minneapolis; 2Hennepin County Medical Center, Univ of MN, Minneapolis; 3Univ of Michigan, Ann Arbor.

    Background: To better risk stratify heart transplants, we developed a continuous heart donor risk index (HDRI) based on heart donors to quantify heart allograft failure.Methods:…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 22
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences